A Double-Blind, Placebo and Active-Controlled Evaluation of the Safety and Efficacy of Cariprazine in the Acute Exacerbation of Schizophrenia
A Double-Blind, Placebo and Active-Controlled Evaluation of the Safety and Efficacy of Cariprazine in the Acute Exacerbation of Schizophrenia
The objective of this study is to evaluate the efficacy, safety, and tolerability of cariprazine relative to placebo for the treatment of acute exacerbation of schizophrenia.
Inclusion Criteria:
Exclusion Criteria:
Bucharest, 041914, Romania
Bucharest, 41914, Romania
Bucharest, 41914, Romania
Craiova, 200745, Romania
Timișoara, 300736, Romania
Orekhovo-Zuyevo, Moscow Oblast 142601, Russia
Arkhangelsk, 163530, Russia
Chelyabinsk, 454087, Russia
Chita, 672090, Russia
Gatchina, 188357, Russia
Saint Petersburg, 190121, Russia
Saint Petersburg, 192019, Russia
Saint Petersburg, 192019, Russia
Saint Petersburg, 1922019, Russia
Saint Petersburg, 193167, Russia
Saint Petersburg, 197341, Russia
Saratov, 410028, Russia
Village Glevakha, Kyiv Oblast 08613, Ukraine
Dnipropetrovsk, 49005, Ukraine
Dnipropetrovsk, 49027, Ukraine
Donetsk, 83008, Ukraine
Kharkiv, 61068, Ukraine
Kharkiv, 61068, Ukraine
Kyiv, 04080, Ukraine
Lviv, 79021, Ukraine
Poltava, 36006, Ukraine
Simferopol, 95006, Ukraine